Evidence map›Paper›PMID 21128174›Full record

ArticleNucleosides, nucleotides & nucleic acids2010

Labeled nucleoside triphosphates with reversibly terminating aminoalkoxyl groups.

Daniel Hutter, Myong-Jung Kim, Nilesh Karalkar, Nicole A Leal, Fei Chen, Evan Guggenheim, Visa Visalakshi, Jerzy Olejnik, Steven Gordon, Steven A Benner

Abstract read
In one paragraph

Article in Nucleosides, nucleotides & nucleic acids, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Engineering a Virus-Derived X Family DNA Polymerase FvPolX for de novo DNA Synthesis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Synthesis of O-Amino Sugars and Nucleosides.Molecules (Basel, Switzerland) · 2018
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Daniel HutterFoundation for Applied Molecular Evolution, Gainesville, FL 32604, USA. sbenner@ffame.org
Myong-Jung Kim
Nilesh Karalkar
Nicole A Leal
Fei Chen
Evan Guggenheim
Visa Visalakshi
Jerzy Olejnik
Steven Gordon
Steven A Benner

Funding

Alkoxylamine nucleosides for sequencing by synthesisR42HG003668 · NHGRI · INTELLIGENT BIO-SYSTEMS, INC. · PI BENNER, STEVEN A · 2008 to 2009
$933k
Multipurpose reversible terminatorsR41HG004589 · NHGRI · FIREBIRD BIOMOLECULAR SCIENCES, LLC · PI HUTTER, DANIEL · 2008 to 2008
$100k
NHGRI NIH HHS 2R42 HG003668-02ANHGRI NIH HHS R41 HG004589NHGRI NIH HHS R42 HG003668
6 · The paper itself

Abstract

Nucleoside triphosphates having a 3'-ONH₂ blocking group have been prepared with and without fluorescent tags on their nucleobases. DNA polymerases were identified that accepted these, adding a single nucleotide to the 3'-end of a primer in a template-directed extension reaction that then stops. Nitrite chemistry was developed to cleave the 3'-ONH₂ group under mild conditions to allow continued primer extension. Extension-cleavage-extension cycles in solution were demonstrated with untagged nucleotides and mixtures of tagged and untagged nucleotides. Multiple extension-cleavage-extension cycles were demonstrated on an Intelligent Bio-Systems Sequencer, showing the potential of the 3'-ONH₂ blocking group in "next generation sequencing."

Indexed as

DNA-Directed DNA PolymeraseDNA PrimersFluorescent DyesMolecular StructureNucleosidesPolyphosphatesSequence Analysis, DNADNA-Directed DNA PolymeraseDNA PrimersFluorescent DyesNucleosidesPolyphosphates

Identifiers

PMID21128174
PMCPMC3858015

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.